Products and Services

Products and Services in Medicine: the news, the names and what changed.

  • 15 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Products and Services


theglobeandmail.com > investing > markets > stocks > MOH > pressreleases > 8103873 > oscar-health-vs-molina-which-healthcare-stock-is-a-better-buy

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?

15+ min ago   (433+ words) The Globe and Mail Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy? The U.S. health insurance industry benefits from diversified, affordable plans that support stable premium revenues and contract retention. However, stricter Medicaid eligibility requirements and declining ACA…...


marketscreener.com > quote > stock > BITTIUM-OYJ-1412471 > graphics-relative-strength

Bittium Oyj: Relative Strength Chart - Stock Nasdaq Helsinki

5+ hour, 43+ min ago   (36+ words) Compare Bittium Oyj with the company of your choice via a Relative Strength chart. Real-time BITTI price, Nasdaq Helsinki stock exchange Relative Strength Chart Bittium Oyj All financial news and data tailored to specific country editions...


seekingalpha.com > article > 4954846-relay-the-recent-market-excitement-ignores-the-reality-of-clinical-risks-and-patent-cliffs

Relay: The Recent Market Excitement Ignores The Reality Of Clinical Risks And Patent Cliffs

3+ hour, 59+ min ago   (113+ words) Relay is rated Hold despite a 175% rally, given overvaluation relative to a risk-adjusted fair value of $13.53 per share. Read more on RLAY stock here. - Relay Therapeutics is rated Hold despite a 175% rally, given overvaluation relative to a risk-adjusted fair value…...


okcfox.com > features > living-oklahoma > cvs-caremark-joins-living-oklahoma-to-explain-pharmacy-benefits-as-viewers-weigh-plans

CVS Caremark joins Living Oklahoma to explain pharmacy benefits as viewers weigh plans

6+ hour, 20+ min ago   (87+ words) KOKH CVS Caremark joins Living Oklahoma to explain pharmacy benefits as viewers weigh plans Our friends from CVS Health are joining us on Living Oklahoma to talk about Pharmacy Benefits. We're reaching to time of year where people are looking…...


finance.yahoo.com > healthcare > articles > drug-development-inputs-services-stocks-150739628.html

Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers

6+ hour, 35+ min ago   (629+ words) Wrapping up Q2 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Laboratories (NYSE:CRL) and its peers. The 8 drug development inputs & services stocks we track reported a very strong Q2. As…...


finance.yahoo.com > healthcare > articles > thermo-fisher-scientific-outperforms-strong-161130783.html

Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences Recovery

5+ hour, 32+ min ago   (450+ words) Yahoo Finance Oops, something went wrong U.S. markets close in 2h 34m Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences Recovery Diamond Hill Capital, a First Eagle Investment Management company, issued its Q3 2026 investor letter for its "Large Cap Strategy". The letter…...


marketscreener.com > quote > stock > ROYALTY-PHARMA-PLC-10/84/35084 > graphics-relative-strength

Royalty Pharma plc: Relative Strength Chart - Stock Nasdaq

4+ hour, 18+ min ago   (37+ words) Compare Royalty Pharma plc with the company of your choice via a Relative Strength chart. Real-time RPRX price, Nasdaq stock exchange Relative Strength Chart Royalty Pharma plc All financial news and data tailored to specific country editions...


seekingalpha.com > article > 4954763-supernus-pharmaceuticals-merger-priced-retreat-reads-reverse-takeover

Supernus Pharmaceuticals: The Merger Is Priced Like A Retreat, But Reads Like A Reverse Takeover

8+ hour, 2+ min ago   (93+ words) Seeking Alpha - Supernus Pharmaceuticals merges with Indivior, gaining operational control and exposure to a larger, cash-generating CNS and addiction platform. - SUPN’s growth products now comprise 80% of revenue, with Qelbree and ZURZUVAE driving robust prescription and sales growth. - Combined entity targets…...


marketscreener.com > quote > stock > EMERGENT-BIOSOLUTIONS-INC-36547 > graphics-relative-strength

Emergent BioSolutions Inc.: Relative Strength Chart - Stock NYSE

8+ hour, 2+ min ago   (37+ words) Compare Emergent BioSolutions Inc. with the company of your choice via a Relative Strength chart. Real-time EBS price, NYSE stock exchange Relative Strength Chart Emergent BioSolutions Inc. All financial news and data tailored to specific country editions...


gurufocus.com > news > 9126926 > mrsh-swot-analysis-strong-growth-potential-amid-legal-challenges-revealed-in-10q-filing

MRSH SWOT Analysis: Strong Growth Potential Amid Legal Challenges Revealed in 10-Q Filing

17+ hour ago   (128+ words) What is MRSH's GF Score? MRSH's GF Score™ is 82/100, indicating a strong overall financial position with notable strengths in profitability and growth. Is MRSH overvalued or undervalued? MRSH is currently undervalued by 27.0%, with a GF Value™ of $255.55 compared to its…...